M.S. in Translational Medicine
The Master of Science in Translational Medicine (MSTM) is a two-year master’s degree program at the Irell & Manella Graduate School of Biological Sciences at City of Hope.
What Is Translational Medicine?
Translational medicine is an interdisciplinary approach that aims to translate basic science discoveries made in laboratories into potential treatments or diagnostic tools to improve human health.
This master of translational medicine program at City of Hope is aimed at providing students with an applied research experience and an in-depth understanding of how to translate basic research into medical products from the perspectives of both academic research (discovery) and downstream commercial development. Graduates will be uniquely positioned to begin research laboratory careers in the biotech/pharmaceutical industry, clinical or academic laboratories, or pursue further education at the doctoral level, medical education or both.
Students
Alumni
Class of 2024
- Hannah Ceballos
- Louis Izuagi
- Victor Lee
- Carol Tao
- William Yao
- Eric Perez
Class of 2023
Class of 2022
Class of 2021
Learn more about the Irell & Manella Graduate School of Biological Sciences at City of Hope.
Research at City of Hope
Need Help?
Latest Graduate School News
The distinguished faculty at the Irell & Manella Graduate School of Biological Sciences have made major contributions in biological sciences and biomedicine. They are widely recognized as leaders in their fields, shaping the future of cancer and cancer treatment science through cutting-edge research and innovative approaches.
Postdoctoral fellows at City of Hope contribute significantly to our understanding of cancer, pushing forward innovative approaches influencing cancer treatment’s future.
The graduate students at the Irell & Manella Graduate School of Biological Sciences are driving progress in cancer and cancer treatment science, supported by a strong educational foundation and a research environment that encourages independent thought and motivates them to challenge existing dogma.